Cart
sales@molnova.com
SB-225002
CAS No. 182498-32-4
SB-225002( SB225002 )
Catalog No. M12815 CAS No. 182498-32-4
A potent, selective non-peptide CXCR2 antagonist with IC50 of 22 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 5MG | 41 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 220 | In Stock |
|
| 100MG | 395 | In Stock |
|
| 200MG | 604 | In Stock |
|
| 500MG | 918 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSB-225002
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective non-peptide CXCR2 antagonist with IC50 of 22 nM.
-
DescriptionA potent, selective non-peptide CXCR2 antagonist with IC50 of 22 nM; displays >150-fold selectivity over CXCR1; potently inhibits human and rabbit neutrophil chemotaxis induced by both IL-8 and GROalpha in vitro; selectively blocks IL-8-induced neutrophil margination in rabbits.
-
In Vitro——
-
In Vivo——
-
SynonymsSB225002
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorCXCR2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number182498-32-4
-
Formula Weight352.1402
-
Molecular FormulaC13H10BrN3O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NC1=CC=C([N+]([O-])=O)C=C1O)NC2=CC=CC=C2Br
-
Chemical NameUrea, N-(2-bromophenyl)-N'-(2-hydroxy-4-nitrophenyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. White JR, et al. J Biol Chem. 1998 Apr 24;273(17):10095-8.
2. Auten RL, et al. J Pharmacol Exp Ther. 2001 Oct;299(1):90-5.
3. Manjavachi MN, et al. Eur J Pain. 2010 Jan;14(1):23-31.
molnova catalog
related products
-
PF-04136309
PF-4136309 (INCB8761) is a potent, selective, competitive, reversible full CCR2 antagonist with IC50 of 2-5 nM.
-
Ladarixin
A novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM.
-
Vicriviroc maleate
A potent, highly selective, and orally bioavailable CCR5 antagonist with Ki of 2.5 nM.
